pharmaceutical

Showing 15 posts of 792 posts found.

kress

Syntimmune brings in new CEO from Biogen

January 4, 2018
Syntimmune, biotech, drugs, pharma, pharmaceutical

Syntimmune has revealed that it has brought in a new CEO to begin the new year, with the appointment of …

eye-1173863_960_720

Spark’s bright idea on $850,000 blindness gene therapy

January 3, 2018
Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical

Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

J&J’s predicted blockbuster depression posts P2 data

January 3, 2018
Research and Development Johnson & Johnson, biotech, depression, drugs, pharma, pharmaceutical

Johnson & Johnson has revealed Phase 2 data for its treatment for depression, esketamine, and the results are positive. The …

Novartis image

Novartis’ Kisqali gains breakthrough status in premenopausal breast cancer

January 3, 2018
Research and Development, Sales and Marketing Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received a major boost in its efforts to broaden use of its CDK4/6 inhibitor, by receiving a breakthrough …

mallinckrodt

Mallinckrodt bolsters business with $1.2bn buyout

January 3, 2018
Research and Development, Sales and Marketing Mallinckrodt, drugs, pharma, pharmaceutical, sucampo

Mallinckrodt has endured a tough 2017, with its share price falling by half over the course of the year. This …

Winter crisis hits, NHS hospitals cancel non-emergency operations

January 3, 2018
Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

There was ample warning that the NHS looked set to face another difficult winter season, the predictions now look to …

age

Diabetes drugs show potential in treating Alzheimer’s

January 3, 2018
Research and Development Alzheimer's disease, biotech, drugs, pharma, pharmaceutical

A group of researchers at Lancaster University have identified a drug currently used to treat type 2 diabetes that has …

epidiolex-100mg-carton-bottle-unenhanced-0074c-j10

GW Pharma applies to both EU and US for lead product

January 2, 2018
Manufacturing and Production, Sales and Marketing GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharmaceuticals had a busy festive period, after it announced that it had submitted to both the EU and the …

Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018
Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …

dermapace-product

FDA approves shock wave wound healing device

January 2, 2018
Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …

mylan_building

Mylan and Biocon biosimilar approval expands to Brazil

January 2, 2018
Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …

valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018
Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …

Novartis hit by court loss, could spur numerous cases across industry

December 22, 2017
Medical Communications, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical

In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held …

Roche boosts oncology portfolio with $1.7bn acquisition

December 22, 2017
Medical Communications, Sales and Marketing Roche, biotech, drugs, ignyta, pharma, pharmaceutical

Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for …

nerve-cell-2213009_960_720

Eisai and Biogen Alzheimer’s drug stumbles at P2

December 21, 2017
Medical Communications, Research and Development Biogen, Eisai, biotech, drugs, pharma, pharmaceutical

Only a few months ago, it was announced that Eisai had decided to opt into the development process of BAN2401. …

The Gateway to Local Adoption Series

Latest content